Evaluation and forecasting methods to estimate number of patients with non-Hodgkin lymphoma: a systematic literature review.

ABSTRACT:

Background

Non-Hodgkin lymphoma (NHL) is the most common hematologic cancer in the US. Validated projections of NHL cases are important for various stakeholders. The study aimed to identify and characterize methods forecasting NHL incidence, prevalence, and number of treatment eligible patients with NHL by line of therapy (LoT). In addition, methods evaluating the performance of cancer forecasting methods were also identified and utilized in selecting the most robust projection method applicable to NHL disease setting.

Methods

A comprehensive search was conducted in MEDLINE and EMBASE databases, covering January 2002 to April 2024 for English-language studies reporting methods evaluating cancer count estimation and NHL projection methods. Study characteristics were extracted

SUBMITTER: Lin D 

PROVIDER: S-EPMC12539154 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature